Institutional Ownership Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 241,754 shares, which have been reported (via 13F filing form) to have a value of $531,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Optiver Holding B.V.
Amsterdam, P7 |
Aug 14, 2024 Q2 2024 |
87,352
shares
|
$200,036
0.0% of portfolio
|
Q2 2024
Added 23.79%
|
|
|
Exchange Traded Concepts, LLC
|
Aug 13, 2024 Q2 2024 |
86,237
shares
|
$197,482
0.0% of portfolio
|
Q2 2024
Reduced 23.73%
|
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
43,524
shares
|
$99,669
0.0% of portfolio
|
Q1 2024
Reduced 4.81%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
23,527
shares
|
$53,876
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
412
shares
|
$943
0.0% of portfolio
|
Q4 2022
Added 234.96%
|
|
|
Ubs Group Ag
|
Aug 13, 2024 Q2 2024 |
297
shares
|
$680
0.0% of portfolio
|
Q2 2024
Added 41.43%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 01, 2024 Q2 2024 |
205
shares
|
$469
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Steward Partners Investment Advisory, LLC
|
Aug 08, 2024 Q2 2024 |
200
shares
|
$458
0.0% of portfolio
|
Q4 2023
Reduced 60.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Jul 23, 2024 Q2 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|